ACE inhibitors- Right or Wrong? | COVID 19 episode artwork

EPISODE · Apr 26, 2020 · 35 MIN

ACE inhibitors- Right or Wrong? | COVID 19

from TopMedTalk

ACE inhibitors (angiotensin converting enzyme inhibitors) have been mentioned frequently in this series over the last month. This piece sees the long promised focus on ACE and the effects of estrogen as a way of dealing with some of the potentially fatal symptoms caused by COVID 19. It's still early days in the battle against this terrible virus, this piece presents some speculation as to where the conflict may head to. TopMedTalk provides evidence based discussions, here we ask how more evidence can be gathered as tantalizing theories emerge about dealing more effectively with these patients. Presented by Desiree Chappell with Monty Mythen and additional questions from Mike Grocott, alongside their guest Hugh Montgomery, Intensive Care Society Board Member and, Professor of Cardiovascular Genetics and Critical Care University College London. Thank you to our sponsor Edwards Lifesciences. Edwards clinical education (ECE): https://www.edwards.com/clinicaleducation

Episode metadata supplied by the publisher feed · Published Apr 26, 2020

Embed this episode

NOW PLAYING

ACE inhibitors- Right or Wrong? | COVID 19

0:00 35:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of TopMedTalk?

This episode is 35 minutes long.

When was this TopMedTalk episode published?

This episode was published on April 26, 2020.

Can I download this TopMedTalk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!